SCHEMBL175354

SCHEMBL175354

Nc1cccoc1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17530314 0.70
SCHEMBL305347 0.70 ALDH1A1 (0.54)
SCHEMBL17547084 0.69
SCHEMBL1981395 0.69 ALDH1A1 (0.47)
SCHEMBL284309 0.68
SCHEMBL980904 0.68
SCHEMBL29419501 0.68
SCHEMBL5925751 0.68
SCHEMBL2763051 0.68
SCHEMBL4950388 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600763-B2 Compositions and methods for the delivery of therapeutic biologics for treatment of disease HALOZYME HYPERCON, INC. (US) 2026-04-14 US disclosed
EP-4719358-A2 ENCAPSULATION OF ACTIVE PHARMACEUTICAL INGREDIENTS The General Hospital Corporation (US) 2026-04-08 EP disclosed
US-20260074073-A1 Biomarker for Seronegative Rheumatoid Arthritis MAYO FOUND MEDICAL EDUCATION & RES (US) 2026-03-12 US disclosed
EP-4651944-A1 INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF Ventus Therapeutics U.S., Inc. (US) 2025-11-26 EP disclosed
EP-4638446-A1 THIADIAZOLE DERIVATIVES AS INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF Ventus Therapeutics U.S., Inc. (US) 2025-10-29 EP disclosed
US-20250302768-A1 NANOPARTICLE DOPED POLYETHYLENE GLYCOL BASED GELS AND MEDICAL DEVICES FOR DRUG DELIVERY THE GENERAL HOSPITAL CORPORATION 2025-10-02 US disclosed
CN-119655374-A Active substance for strengthening cardiovascular functions of dogs and cats, and preparation method and application of soft capsule 卫仕宠物营养研究院(芜湖)有限公司 2025-03-21 CN disclosed
US-20250026811-A1 Compositions and Methods for the Delivery of Therapeutic Biologics for Treatment of Disease HALOZYME HYPERCON, INC. 2025-01-23 US disclosed
WO-2024250016-A2 ENCAPSULATION OF ACTIVE PHARMACEUTICAL INGREDIENTS THE GENERAL HOSPITAL CORPORATION (US) 2024-12-05 WO disclosed
WO-2024233767-A1 INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2024-11-14 WO disclosed
US-4855454-A CHEMICAL INTERMEDIATES; SWEETENERS PFIZER INC. (US) 1989-08-08 US disclosed
US-4804782-A ARTIFICIAL SWEETENER PFIZER, INC. (US) 1989-02-14 US disclosed
US-4517379-A ARTIFICIAL SWEETENER PFIZER INC. (US) 1985-05-14 US disclosed
EP-0069811-B1 BRANCHED AMIDES OF L-ASPARTYL-D-AMINO ACID DIPEPTIDES AND COMPOSITIONS THEREOF PFIZER INC. (US) 1984-10-24 EP disclosed
EP-0034876-B1 BRANCHED AMIDES OF L-ASPARTYL-D-AMINO ACID DIPEPTIDES AND COMPOSITIONS THEREOF PFIZER INC. (US) 1984-08-29 EP disclosed
US-4454328-A SWEETENERS PFIZER INC. (US) 1984-06-12 US disclosed
US-4411925-A STABLE SWEETENERS PFIZER INC. (US) 1983-10-25 US disclosed
US-4399163-A ARTIFICIAL SWEETENERS PFIZER INC. (US) 1983-08-16 US disclosed
EP-0069811-A1 Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof PFIZER INC. (US) 1983-01-19 EP disclosed
EP-0034876-A2 Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof PFIZER INC. (US) 1981-09-02 EP disclosed